Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

CLRB Cellectar Biosciences Inc

0,31

0,0104 (3,47%)

15 Mär 2025 - Geschlossen

Verzögert um 15 Minuten

Form S-1 - General form for registration of securities under the Securities Act of 1933

0001410578-25-000060.txt

Cellectar Biosciences (NASDAQ:CLRB)
Historical Stock Chart
Von Feb 2025 bis Mär 2025

Click Here for more Cellectar Biosciences Charts.

Cellectar Biosciences (NASDAQ:CLRB)
Historical Stock Chart
Von Mär 2024 bis Mär 2025

Click Here for more Cellectar Biosciences Charts.

News Cellectar Biosciences Inc

Form 8-K - Current report
Donnerstag 13 März 2025 (3 Tage vor) • Edgar (US Regulatory)

Cellectar Biosciences Reports Financial Results for Year Ended 2024 and Provides a Corporate Update
Donnerstag 13 März 2025 (3 Tage vor) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Donnerstag 13 März 2025 (3 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 13 März 2025 (4 Tage vor) • Edgar (US Regulatory)

Cellectar Biosciences to Present at the 37th Annual Roth Conference
Dienstag 11 März 2025 (5 Tage vor) • GlobeNewswire Inc.

Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Thursday, March 13, 2025
Mittwoch 5 März 2025 (2 Wochen vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 18 Februar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 18 Februar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 18 Februar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 18 Februar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 18 Februar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Freitag 14 Februar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Weitere Cellectar Biosciences Inc News-Artikel

Financial Select Sector

Euro vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen